Literature DB >> 21881473

Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease.

Genko Oyama1, Kelly D Foote, Sanjay S Iyer, Pamela Zeilman, Nelson Hwynn, Charles E Jacobson, Irene A Malaty, Hubert H Fernandez, Ramon L Rodriguez, Michael S Okun.   

Abstract

BACKGROUND: Respiratory dyskinesia is a rare but disabling complication of levodopa therapy for Parkinson disease; however, its treatment has been limited to medication optimization. CASE REPORT: A 72-year-old woman with a 6-year history of Parkinson disease presented with severe and debilitating levodopa-induced respiratory dyskinesia, which manifested with a short and shallow breathing pattern and panting. These symptoms were observed coincident with limb and truncal dyskinesias. Both respiratory and limb/trunk dyskinesias were addressed by the implantation of a unilateral globus pallidus interna deep brain stimulator (GPi-DBS).
CONCLUSIONS: Although the mechanism of involvement of the respiratory system in dyskinesia is unknown, GPi-DBS seems to be a potentially viable treatment option for these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881473     DOI: 10.1097/NRL.0b013e318217367b

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  4 in total

1.  Evaluation, treatment, and analysis of a rare case of motor speech systems dyscoordination syndrome.

Authors:  Diana Van Lancker Sidtis; John J Sidtis
Journal:  Cogent Med       Date:  2017-10-05

2.  Respiratory dyskinesia in a patient with Parkinson disease successfully treated with STN DBS.

Authors:  Tao Xie; Rui Guan; Julia Staisch; Vernon L Towle; Peter Warnke
Journal:  Neurology       Date:  2015-07-02       Impact factor: 9.910

3.  Biphasic (Subtherapeutic) Levodopa-Induced Respiratory Dysfunction in Parkinson Disease.

Authors:  Veerle A van de Wetering-van Dongen; Alberto J Espay; Luca Marsili; Andrea Sturchio; Susanne Ten Holter; Bastiaan R Bloem; Maarten J Nijkrake
Journal:  Neurol Clin Pract       Date:  2021-08

Review 4.  Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

Authors:  Dhanya Vijayakumar; Joseph Jankovic
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.